Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

lymphosarcoma - Clinical Profile, Treatments & Trials | Kisho | Kisho

Rare Disease

lymphosarcoma

MONDO:0004638

Also known as:diffuse lymphomamalignant lymphoma (category)

Find Clinical TrialsTrials

Overview

An antiquated term that refers to a non-Hodgkin lymphoma composed of small and medium sized lymphocytes.

Treatments1 FDA approved

Clinical Trials223 registered · 64 recruiting

Diagnosis

Biomarker and diagnostic research for lymphosarcoma has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

1 FDA-approved treatment is available for lymphosarcoma, including CHLORAMBUCIL (LEUKERAN, approved 1957).

Approved Therapies

Brand Name	Generic Name	Mechanism	Approved	Market Status

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

223 clinical trials registered, 64 recruiting. Interventions under study include drug therapy, other interventions, biologic therapy, and medical devices. Pipeline includes 2 PHASE4, 11 PHASE3, 44 PHASE2. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT05929612](https://clinicaltrials.gov/study/NCT05929612)

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 12:47 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

GARD

Genetic and Rare Diseases Info Center

GARD:6946

Questions for Your Care Team

→What are the benefits and potential side effects of LEUKERAN for managing lymphosarcoma?
→Are any of the 223 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Laboratory research	7	29%
Disease patterns and progression	7	29%
Patient case studies	4	17%
Research summaries	3	13%
Testing and diagnosis research	2	8%
New treatment approaches	1	4%

lymphosarcoma

Overview

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

External Resources

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications